Command Combination Regimens and Ns5a Development In Hepatitis C Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 9 years ago on Monday, March 2, 2015, according to the United State Patent & Trademark Office
Word Mark Command Combination Regimens and Ns5a Development in Hepatitis C
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Bristol-Myers Squibb Company of New York, NY

View all trademarks for Bristol-Myers Squibb Company
Other Trademarks for Bristol-Myers Squibb Company
Serial Number 85354235
Status Date Monday, March 2, 2015
Filing Date Monday, March 2, 2015
Attorney Marilyn Kelly

Correspondent

Marilyn F. Kelly
BRISTOL-MYERS SQUIBB COMPANY
TRADEMARKS DEPT. - MAILSTOP D33-05
P.O. BOX 4000
PRINCETON NJ 08648-4000

Case File Statements

Disclaimer with Predetermined Text "Combination Regimens and Ns5a Development in Hepatitis C"
Goods & Services Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use, namely, relating to combination of regimens that affect NS5A development in the treatment of hepatitis C

Classifications

International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Wednesday, June 29, 2011
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.